Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Derm CasesDermatology / Infectious Diseases / Emergency Medicine

Derm Cases · Dermatology / Infectious Diseases / Emergency Medicine

OSCE — antimicrobials for skin infection: cellulitis vs abscess, stewardship, and when to escalate

An 8-minute OSCE station on distinguishing cellulitis/erysipelas from abscess and non-infectious red legs, choosing empiric antibiotics and duration concepts, incision-and-drainage when indicated, and MRSA/red-flag recognition.

8 minosce1 min readVerification in progress

Target exams

NEET-PGINICETUSMLEPLABMRCP
On this page
Study tools

Target exams

NEET-PGINICETUSMLEPLABMRCP
Prompt
An 8-minute OSCE station on distinguishing cellulitis/erysipelas from abscess and non-infectious red legs, choosing empiric antibiotics and duration concepts, incision-and-drainage when indicated, and MRSA/red-flag recognition.

Brief (to candidate)

A 45-year-old has an acutely red, hot, painful lower leg with fever. There is no fluctuance. A second patient has a tender pointing boil with central pustule. You have 8 minutes to diagnose, decide antibiotics versus drainage, and apply stewardship and safety-netting.

[7]

Candidate instructions

  1. Differentiate cellulitis/erysipelas, abscess/furuncle, and mimics (stasis dermatitis, DVT, contact dermatitis).
  2. Choose empiric oral vs IV pathway using severity.
  3. State when incision and drainage is primary therapy.
  4. Apply antibiotic stewardship (duration, avoid unnecessary broad agents).
  5. Identify necrotising infection red flags.
[4]

Examiner checklist (mark each domain / 10)

DomainKey actions expected
Cellulitis vs erysipelasSpreading dermal/subcutaneous infection; erysipelas more superficial with raised advancing edge often strep; mark borders, assess systemic features[1][2]
AbscessFluctuant collection → incision and drainage is definitive; antibiotics adjunct when systemic features, cellulitis surround, immunocompromise, or face/hand special sites per protocol[3]
Empiric therapy conceptsCover Streptococcus/MSSA for typical non-purulent cellulitis; add MRSA-active agents when purulent infection, known MRSA, or local epidemiology dictates; escalate to IV if septic/rapidly progressive/unable to take oral[1][4]
StewardshipAvoid prolonged antibiotics for non-infectious “red leg”; reassess 48–72 h; short evidence-based courses when responding; do not treat colonisation with endless antibiotics
MimicsBilateral chronic stasis changes ≠ bilateral cellulitis; consider DVT, lipodermatosclerosis flare, contact dermatitis, gout
Red flagsPain out of proportion, crepitus, rapid progression, purple bullae, anaesthesia → necrotising fasciitis pathway (urgent surgery + broad IV therapy)[5]
PreventionTreat tinea pedis/entry points; compression for venous disease once infection controlled; glycaemic control

Model key actions

  • Treat non-purulent cellulitis with appropriately targeted antibiotics and severity-based route.[1][2]
  • Drain abscesses; do not rely on antibiotics alone when pus is present.[3]
  • Exclude necrotising infection and common non-infectious mimics.[5]

Common errors

  • Antibiotics alone for drainable abscess.
  • Treating bilateral chronic stasis dermatitis as recurrent cellulitis for months.
  • Missing necrotising fasciitis red flags.
  • Endless broad-spectrum therapy without reassessment.
  • Ignoring portal of entry (tinea, ulcer).
[1] [3] [5]
References7ShowHide
  1. [1]Rrapi R, Chand S, Kroshinsky D. Cellulitis: A Review of Pathogenesis, Diagnosis, and Management. The Medical clinics of North America, 2021.PMID 34059247
  2. [2]Holt RIG, Cockram CS, Ma RCW, et al. Diabetes and infection: review of the epidemiology, mechanisms and principles of treatment. Diabetologia, 2024.PMID 38374451
  3. [3]Hatlen TJ, Miller LG. Staphylococcal Skin and Soft-Tissue Infections. Infectious disease clinics of North America, 2021.PMID 33303329
  4. [4]Yosipovitch G, Nedorost ST, Silverberg JI, et al. Stasis Dermatitis: An Overview of Its Clinical Presentation, Pathogenesis, and Management. American Journal of Clinical Dermatology, 2023.PMID 36800152
  5. [5]Gardini G, Gregori N, Matteelli A, et al. Mycobacterial skin infection. Current Opinion in Infectious Diseases, 2022.PMID 35067521
  6. [6]Reynolds RV, Yeung H, Cheng CE, et al. Guidelines of care for the management of acne vulgaris. Journal of the American Academy of Dermatology, 2024.PMID 38300170
  7. [7]Shu Z, Cao J, Li H, et al. Efficacy and safety of first- and second-line antibiotics for cellulitis and erysipelas: a network meta-analysis of randomized controlled trials Arch Dermatol Res, 2024.PMID 39240378
PreviousOSCE — antihistamines and itch: urticaria pathway vs non-histaminergic pruritusDermatology / Allergy / TherapeuticsNextOSCE — lower-limb cellulitis vs erysipelas and necrotising red flagsDermatology / Infectious Diseases / Emergency Medicine